Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Published 23/11/2022, 12:38
Updated 23/11/2022, 13:40
© Reuters.  Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.
  • Kalera Public Limited Company (NASDAQ: KAL) rose 30% to $0.1183 in pre-market trading after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
  • OpGen, Inc. (NASDAQ: OPGN) rose 19.2% to $0.23 in pre-market trading after declining around 10% on Tuesday. The company recently posted downbeat quarterly results.
  • Cosmos Holdings Inc.. (NASDAQ: COSM) rose 19.1% to $0.3899 in pre-market trading after surging around 87% on Tuesday. Cosmos Holdings recently posted a Q3 loss of $0.08 per share.
  • Core Scientific, Inc. (NASDAQ: CORZ) rose 18.9% to $0.1596 in pre-market trading after declining 20% on Tuesday.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) rose 17.2% to $2.38 in pre-market trading.
  • Venus Concept Inc. (NASDAQ: VERO) shares rose 15.3% to $0.2522 in pre-market trading after climbing over 9% on Tuesday. Venus Concept recently announced completion of $6.72 million private placement financing.
  • NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) rose 14.6% to $1.49 in pre-market trading after gaining over 8% on Tuesday.
  • ObsEva SA (NASDAQ: OBSV) rose 10.1% to $0.2125 in pre-market trading. ObsEva shares jumped over 16% on Tuesday after the company announced the sale of the ebopiprat license agreement to XOMA for up to $113 million..
  • Manchester United plc (NYSE: MANU) rose 9.6% to $16.38 in pre-market trading after the company announced a process to explore strategic alternatives.
  • Palisade Bio, Inc. (NASDAQ: PALI) rose 7% to $4.30 in pre-market trading. Palisade Bio shares jumped 81% on Tuesday after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel function following surgery.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Don’t forget to check out our premarket coverage here .

Losers

  • Motorsport Games Inc. (NASDAQ: MSGM) fell 19.1% to $5.50 in pre-market trading after jumping 51% on Tuesday. The company recently posted a Q3 loss of $7.29 per share.
  • AGBA Group Holding Limited (NASDAQ: AGBA) shares fell 14.4% to $4.25 in pre-market trading after dipping 21% on Tuesday.
  • FOXO Technologies Inc. (NYSE: FOXO) shares fell 11.7% to $0.6360 in pre-market trading after climbing around 48% on Tuesday.
  • Nordstrom, Inc. (NYSE: JWN) shares fell 9.5% to $20.51 in pre-market trading. Nordstrom posted upbeat earnings and sales results for its third quarter. The company said it expects full-year revenue growth to be between 5% and 7% and adjusted earnings to be between $2.30 and $2.60 per share.
  • Kaspien Holdings Inc. (NASDAQ: KSPN) fell 9.5% to $0.8310 in pre-market trading after declining over 6% on Tuesday.
  • Autodesk (NASDAQ:ADSK), Inc. (NASDAQ: ADSK) shares fell 8.7% to $190.80 in pre-market trading. Autodesk posted in-line earnings for its third quarter, but issued weak guidance for the year.
  • PagSeguro Digital Ltd. (NYSE: PAGS) fell 8.4% to $11.00 in pre-market trading after the company reported Q3 sales of R$4.04 billion.
  • Orbital Infrastructure Group, Inc. (NASDAQ: OIG) fell 7.4% to $0.2002 in pre-market trading after dropping over 8% on Tuesday. The company recently reported third-quarter revenue growth of 302.2% year-on-year to $99.8 million, missing the consensus of $132.1 million.
  • Trevi Therapeutics, Inc. (NASDAQ: TRVI) fell 7% to $1.74 in pre-market trading after dropping 6% on Tuesday. Trevi Therapeutics recently appointed David Clark, MD, MRCP as Chief Medical Officer.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.